Model-Informed Precision Dosing / / edited by Jonás Samuel Pérez-Blanco, José Martínez Lanao.

Model-informed precision dosing (MIPD) is an advanced quantitative approach focusing on individualized treatment optimization. MIPD integrates mathematical models of drugs and diseases combined with individual patient characteristics (e.g., genotype, anthropometric factors, and organ function). MIPD...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023.
Year of Publication:2023
Language:English
Physical Description:1 online resource (320 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02101nam a2200301 i 4500
001 993600175804498
005 20230703095537.0
006 m o d
007 cr |||||||||||
008 230703s2023 sz o 000 0 eng d
020 |a 3-0365-6897-2 
035 |a (CKB)5700000000354572 
035 |a (NjHacI)995700000000354572 
035 |a (EXLCZ)995700000000354572 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
050 4 |a RM145  |b .M634 2023 
082 0 4 |a 615.14  |2 23 
245 0 0 |a Model-Informed Precision Dosing /  |c edited by Jonás Samuel Pérez-Blanco, José Martínez Lanao. 
264 1 |a Basel :  |b MDPI - Multidisciplinary Digital Publishing Institute,  |c 2023. 
300 |a 1 online resource (320 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on publisher supplied metadata and other sources. 
520 |a Model-informed precision dosing (MIPD) is an advanced quantitative approach focusing on individualized treatment optimization. MIPD integrates mathematical models of drugs and diseases combined with individual patient characteristics (e.g., genotype, anthropometric factors, and organ function). MIPD has been highlighted as a useful tool for drug dosage selection in both the drug development process and clinical practice and it is a rapidly growing discipline that is supported by the main drug regulatory agencies. Despite the potential benefits of this methodology toward personalized medicine, its application is still limited. The Special Issue presented here includes several PKPD and PBPK models focused on improving the current state of art regarding the PK behaviour of different drugs with the aim of improving the efficacy/safety balance of these treatments and their clinical outcome; the Special Issue is intended to be of particular interest for clinical pharmacologists, pharmacometricians, and specific clinicians who routinely use the considered drugs. 
650 0 |a Drugs  |x Dosage. 
776 |z 3-0365-6896-4 
700 1 |a Pérez-Blanco, Jonás Samuel,  |e editor. 
700 1 |a Lanao, José Martínez,  |e editor. 
906 |a BOOK 
ADM |b 2023-07-08 12:20:14 Europe/Vienna  |f system  |c marc21  |a 2023-04-02 14:12:45 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345666570004498&Force_direct=true  |Z 5345666570004498  |b Available  |8 5345666570004498